Showing results (811-820 of 888) with videos related to

Sort By:
Pageof 89
Proceedings of the National Academy of Sciences of the United States of America|August 15, 2012
High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45Stephanie M Stanford, Rekha G Panchal, Logan M Walker, et al.
Nature Communications|June 11, 2024
Direct RNA sequencing of astronaut blood reveals spaceflight-associated m6A increases and hematopoietic transcriptional responsesKirill Grigorev, Theodore M Nelson, Eliah G Overbey, et al.
Molecular Pharmacology|May 1, 2019
Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory ActivitiesM Michael Dcona, Priyadarshan K Damle, Francisco Zarate-Perez, et al.
Blood|September 9, 1999
Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemiaR N Damle, T Wasil, F Fais, et al.
Genes and Immunity|June 24, 2005
Peripheral blood gene expression profiling in rheumatoid arthritisF M Batliwalla, E C Baechler, X Xiao, et al.
Cells|October 27, 2023
Inducing Angiogenesis in the Nucleus PulposusSheela R Damle, Agata K Krzyzanowska, Maximilian K Korsun, et al.
Molecular Medicine (Cambridge, Mass.)|July 11, 2008
Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritisChunyu Liu, Franak Batliwalla, Wentian Li, et al.
Blood|May 16, 2002
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytesRajendra N Damle, Fabio Ghiotto, Angelo Valetto, et al.
Frontiers in Microbiomes|March 19, 2026
Microbial dysbiosis in melasma through community profilingYugandhar Reddy B S, Chandraprabha Doraiswamy, Deepshikha Singh, et al.
Blood|November 15, 2003
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignanciesJohn F DiJoseph, Douglas C Armellino, Erwin R Boghaert, et al.
Pageof 89